bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.01.11.698917

A dynamic metabolic flux analysis (DMFA) model for performance predictions of diverse CHO cell culture process modes and conditions

Abstract

Bioreactor pH can significantly affect Chinese Hamster Ovary (CHO) cell metabolism, thus impacting glycoprotein titers. However, there is very limited literature on incorporating pH in mathematical models for CHO cell metabolism. To address this limitation, guided by recently published experimental data, we have curated a stoichiometric network and formulated phenotype-driven kinetic expressions to develop a Dynamic Metabolic Flux Analysis (DMFA) model. The DMFA model incorporates Critical Process Parameters (CPPs), notably bioreactor pH, basal and feed media nutrient composition, feeding times, and inoculation cell densities to predict bioreactor performance: cell growth rates, antibody titers, and nutrient and metabolite profiles. The DMFA model was trained on diverse fed-batch data of the CHO VRC01 cell line to regress the kinetic parameters. The models utility was demonstrated through experimentally validated model predictions of CHO-cell performance in intensified fed-batch cultures, perfusion cultures, and cultures with different media. Experimentally validated predictions of a culture with high initial cell density and increased feed addition (intensified fed-batch culture) showed that mAb titers similar to fed-batch culture can be achieved with shorter culture durations. Similarly, experimentally validated predictions of perfusion bioreactor performance showed that coupling historical fed-batch data with computational tools can be leveraged to predict continuous biomanufacturing performance. We thus demonstrate that the developed mathematical model can simulate culture performance outside of the training data set. This supports the predictive robustness of the framework and provides a valuable tool for bioprocess development of diverse culture modes. HighlightsO_LIExperimentally measured fed-batch cell culture data was used to curate a reaction network. This reaction network was integrated with phenotypically driven kinetic expressions to yield a dynamic metabolic flux analysis (DMFA) model. C_LIO_LIThe DMFA model can predict bioprocess performance indicators such as concentration of viable cells, mAb, amino acids, glucose, lactate, and ammonia. C_LIO_LIThe model was developed to make these predictions under various process conditions such as bioreactor pH, media concentrations, feed supplementation schedule, and initial cell densities. C_LIO_LIPredicting and experimentally validating the impact of high initial cell density and increased feed media supplementation yielded in mAb titers similar to traditional fed-batch processes with much shorter culture durations. C_LIO_LIThe application of the DMFA model trained on data from a traditional fed-batch process to predict perfusion bioreactor culture performance was successfully demonstrated and experimentally verified. C_LIO_LIThe impact of AMBIC reference media on cell culture process performance was also predicted and experimentally validated. The predictions of amino acid metabolism yielded insights into improving the media. C_LI

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Venkatarama Reddy, J., Malinov, N., Souvaliotis, J., Papoutsakis, E. T., Ierapetritou, M.. 2026-01-12. A dynamic metabolic flux analysis (DMFA) model for performance predictions of diverse CHO cell culture process modes and conditions. https://doi.org/10.64898/2026.01.11.698917

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Surfactant-Assisted Colorimetric Signal Enhancement in Paper-Based Glucose Sensing

Paper-based colorimetric sensors offer a low-cost and accessible platform for point-of-care (POC) analysis, but enzyme activity loss during coating and drying can weaken analytical signals and require high enzyme loadings or complex immobilization procedures. Although surfactants are widely used to improve wettability in paper-based assays, their potential contribution to colorimetric performance beyond these effects remains unclear. Here, we investigated surfactant-assisted colorimetric signal enhancement in a glucose assay implemented on a 96-puddle paper plate (96-PPP) and identified Tween 20 as the most effective surfactant. Its effect on detection performance became more pronounced as glucose oxidase (GOx) loading decreased; at 0.1 mg/mL GOx, Tween 20 lowered the limit of detection (LoD) from 0.113 to 0.034 mg/mL (approximately 3.3-fold) over a working range of 0-5 mg/mL, despite no statistically significant change in the measured contact angle at this loading. Tween 20 had no appreciable effect on the reaction in solution but preserved 95% of the apparent reaction rate constant after drying, compared with 11% without it, and atomic force microscopy (AFM) revealed a more dispersed dried enzyme morphology on mica. Tween 20-containing sensors also showed slower signal decay during repeated wetting-drying cycles and thermal stress, retained 77% (vs 26%) of the response at 400 mM NaCl, and exhibited within-PPP and between-batch coefficients of variation (CVs) below 10% (vs 12.3-19.5%), while maintaining glucose selectivity over potentially interfering molecules. These results indicate that Tween 20 enhances paper-based glucose sensing beyond wettability, in part by retaining enzyme cascade activity during drying, although the contributions of the individual enzymes and the underlying mechanism remain to be established.

bioengineering↗

Engineering CAR-T cells to remodel the mucin-rich cancer cell glycocalyx

The dense glycocalyx of cancer cells can restrict immune-cell access to surface antigens and limit CAR-T cell activity. Here, we show that mucin density and epitope position determine how glycocalyx remodeling affects CAR-T cell recognition and killing. We identify KLK5 as a human protease that cleaves tumor-associated mucins, increases access to membrane-proximal antigens, and enhances CAR-T cell function. We then engineer CAR-T cells to display or secrete KLK5, enabling remodeling of the tumor glycocalyx during antigen recognition. KLK5-engineered CAR-T cells improved tumor control across multiple xenograft models, and KLK5-secreting MUC17 CAR-T cells produced the strongest in vivo benefit, prolonging survival compared with conventional MUC17 CAR-T cells. These findings show that CAR-T cells can be engineered to breach the mucin-rich glycocalyx while preserving accessible target epitopes.

bioengineering↗

Wall stiffening is a primary contributor to motility loss in Crohn's disease: an electromechanical modeling study

Fibrotic strictures are among the most disabling complications of Crohn's disease, permanently narrowing the bowel and impairing motility, yet no approved therapy reverses them. Chronic inflammation alters pacemaker-network coupling, smooth-muscle excitability, and calcium-dependent contractility, while fibrosis thickens the bowel wall, narrows the lumen, and changes tissue mechanics. The relative contributions of these coupled electrical, contractile, and structural alterations to motility loss remain unclear. To address this gap, we develop an integrated electromechanical finite-element framework for fibrostenosing Crohn's disease that couples a fibrosis-driven growth model with a FitzHugh-Nagumo electromechanical model. A full-factorial 25 design of experiments is used to quantify the relative effects of electrical diffusivity, excitation threshold, peak active stress, wall stiffness, and hypertrophic remodeling on cyclic lumen-volume deformation. Motility is quantified by the standard deviation of lumen volume over one contraction cycle. Within the parameter ranges examined, increased wall stiffness emerged as the dominant contributor to motility loss, followed by impaired smooth-muscle contractility. Changes in excitation threshold, hypertrophic remodeling, and electrical diffusivity produced substantially smaller effects. Pairwise interactions were small relative to the dominant main effects, indicating that the mechanisms contributed largely through their individual effects. Our findings suggest that limiting wall stiffening while preserving smooth-muscle contractile function may provide a therapeutic strategy for maintaining intestinal motility in fibrostenosing Crohn's disease.

bioengineering↗